We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+17.37%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$140M
AUM Growth
+$22.6M
Cap. Flow
+$4.69M
Cap. Flow %
3.36%
Top 10 Hldgs %
25.46%
Holding
159
New
26
Increased
30
Reduced
50
Closed
18

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.14M
2
INTC icon
Intel
INTC
+$1.72M
3
CIEN icon
Ciena
CIEN
+$1.18M
4
LLY icon
Eli Lilly
LLY
+$1.16M
5
PEP icon
PepsiCo
PEP
+$844K

Sector Composition

Rank Sector Weight
1 Healthcare 23.84%
2 Technology 20.82%
3 Consumer Staples 15.19%
4 Industrials 14.56%
5 Financials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
101
Gilead Sciences
GILD
$165B
$416K 0.3%
5,410
+2,250
+71% +$172K
CFG icon
102
Citizens Financial Group
CFG
$30.6B
$396K 0.28%
15,670
-600
-4% -$13.6K
AVGO icon
103
Broadcom
AVGO
$2.05T
$395K 0.28%
12,500
+500
+4% +$14K
EMR icon
104
Emerson Electric
EMR
$88.2B
$388K 0.28%
6,258
-550
-8% -$31.2K
HEI icon
105
HEICO Corp
HEI
$51.5B
$384K 0.27%
3,850
-1,650
-30% -$152K
NFLX icon
106
Netflix
NFLX
$310B
$382K 0.27%
8,400
+2,500
+42% +$106K
JPM icon
107
JPMorgan Chase
JPM
$953B
$378K 0.27%
+4,023
New +$382K
MET icon
108
MetLife
MET
$62B
$378K 0.27%
10,350
-10,350
-50% -$360K
ORCL icon
109
Oracle
ORCL
$429B
$377K 0.27%
6,825
BIIB icon
110
Biogen
BIIB
$30.7B
$368K 0.26%
+1,375
New +$413K
OSK icon
111
Oshkosh
OSK
$9.48B
$362K 0.26%
+5,050
New +$345K
EBS icon
112
Emergent Biosolutions
EBS
$226M
$356K 0.25%
+4,500
New +$335K
AMWD
113
DELISTED
American Woodmark
AMWD
$348K 0.25%
+4,595
New +$263K
IDXX icon
114
Idexx Laboratories
IDXX
$46.3B
$347K 0.25%
1,050
DHI icon
115
D.R. Horton
DHI
$40.9B
$345K 0.25%
+6,225
New +$302K
PYPL icon
116
PayPal
PYPL
$50.1B
$335K 0.24%
1,925
-5,725
-75% -$791K
WY icon
117
Weyerhaeuser
WY
$18.1B
$332K 0.24%
14,775
-500
-3% -$10.1K
TEX icon
118
Terex
TEX
$7.68B
$320K 0.23%
17,050
-350
-2% -$5.57K
SAIC icon
119
Saic
SAIC
$5.33B
$315K 0.23%
4,050
-350
-8% -$28.7K
AZN icon
120
AstraZeneca
AZN
$249B
$312K 0.22%
2,954
ICE icon
121
Intercontinental Exchange
ICE
$84.9B
$309K 0.22%
3,375
-8,775
-72% -$803K
WMT icon
122
Walmart Inc
WMT
$885B
$305K 0.22%
7,641
SCHW
123
Charles Schwab
SCHW
$189B
$299K 0.21%
8,850
LNG icon
124
Cheniere Energy
LNG
$54.2B
$286K 0.2%
5,925
-400
-6% -$17.5K
IRDM icon
125
Iridium Communications
IRDM
$5.25B
$267K 0.19%
+10,502
New +$246K

Similar funds

New England Research & Management's Q2 2020 Portfolio in Review

As of Q2 2020, New England Research & Management held 159 positions worth $140M, up 19% from $117M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

New England Research & Management deployed $4.69M of net new capital in Q2 2020, opening 26 new positions and adding to 30 existing holdings. Its largest new stake was Leidos: 22,479 shares worth $2.11M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Walt Disney, an estimated $2.14M trimmed.

  • New England Research & Management's largest Q2 2020 buy was Leidos: 22,479 shares worth $2.11M.
  • New England Research & Management added most to Waste Management in Q2 2020, an estimated $947K increase.
  • New England Research & Management's biggest Q2 2020 reduction was Walt Disney, cutting an estimated $2.14M.
  • New England Research & Management fully exited Ciena in Q2 2020, selling an estimated $1.18M.
  • New England Research & Management's ten largest holdings make up 25% of its $140M portfolio in Q2 2020.
  • New England Research & Management opened 26 new positions and closed 18 in Q2 2020.
  • New England Research & Management's portfolio value rose 19% quarter-over-quarter to $140M.

Based on New England Research & Management's 13F filing for Q2 2020, filed 15 Jul 2020.